Évaluation de l'implantation des valves cardiaques aortiques percutanées aux hôpitaux universitaires de Strasbourg

The object of this study was to assess the appropriateness of using transcatheter aortic valves in terms of indication, financial and health traceability with regard to the regulatory guidance and the French recommendations. Our analysis was retrospective and included all patients who were implanted aortic valves until June 30, 2011 in our institution. The cohort included 54 patients with an average age of 83 years (range: 71-91). Valve implantation was successful in 50 patients (93%) and 30-day mortality was 14.8%. Despite the fact that some criteria might not comply with recommendations or were missing, the indication of percutaneous valve implantation was always respected. The proof of delivery of health traceability information to the patient was found in only five cases. The health traceability and the financial rating system were completed in 49 and 45 cases, respectively. The indications of aortic valve implantations were appropriate with respect to the French guidelines. Some gaps have been identified regarding the long-term monitoring of patients and the health traceability information delivery. Our survey of professional practice has emphasized the need for traceability and financial recovery. Measures have been implemented to improve the traceability requirements.